COPD Teaching 1760
SN instructed that Breo Ellipta is used regularly as a long term (maintenance) treatment to prevent or decrease wheezing and trouble breathing caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, including chronic bronchitis and emphysema). Instructed that common side effects include, Headache, dry/irritated throat, hoarseness, runny nose, and coughing may occur as your body adjusts to the medication.
Reviewed November 2017
Reviewed for general reference only. Adapt to your patient, agency policy, and scope of practice.
Related teachings
COPD Teaching 825Instructed on the importance of avoiding crowds and poorly ventilated areas.COPD Teaching 2148SN instructed patient on ways to avoid acute exacerbations of chronic obstructive pulmonary disease ( COPD ) by recognizing early warning signs and then taking action to stop them in their tracks. The best way to do this...COPD Teaching 829Instructed on some signs/symptoms of respiratory infection, such as: loss of appetite and rapid pulse and respirations, among others.COPD Teaching 1401The patient was instructed in COPD: Chronic Obstructive Pulmonary Disease or Chronic Obstructive Lung Disease the importance of avoiding bronchopulmonary irritants such as cigarettes smoking, industrial air pollutants, d...